— Know what they know.
Not Investment Advice
Also trades as: TRI.AX (ASX) · $vol 0M

MDBIF OTC

TrivarX Limited
1W: -14.7% 1M: -69.8% 3M: +211.5% YTD: -48.4% 1Y: -66.7% 3Y: -73.0% 5Y: -96.6%
$0.01
-0.00 (-14.74%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $5.0M mcap · 401M float · 0.0008% daily turnover · Short 92% of daily vol

Cash Flow Trends

Operating Cash Flow
-$2M -830.2% ▼
Capital Expenditures
$2M +150366400.0% ▲
5Y CAGR: -3.9%
Free Cash Flow
$0 +100.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$1M +215.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income-$12M-$3M-$1M-$943K-$9M
Depreciation & Amort.$384K$541K$0$52K$6M
Stock-Based Comp.-$33K$42K$0$0$0
Change in Working Capital$670K$238K-$48K$0$0
Other Non-Cash Items$9M$939K-$190K$729K$783K
Operating Cash Flow-$2M-$932K-$1M-$162K-$2M
— Investing Activities —
Capital Expenditures-$3M-$2M-$3M$0-$1M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$3$0$0-$2M$0
Investing Cash Flow-$3M-$2M-$3M-$2M-$1M
— Financing Activities —
Net Debt Issuance-$89K-$40K-$95K-$55K$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$3M-$48K
Financing Cash Flow$3M$2M$5M$3M$4M
Net Change in Cash-$1M-$818K$634K$399K$1M
Cash End of Period$1M$214K$848K$1M$2M
Free Cash Flow-$5M-$3M-$3M-$162K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms